BIOCHEMICAL ANALYSIS OF A NOVEL U1 RNA-ANTIBODY COMPLEX
新型 U1 RNA 抗体复合物的生化分析
基本信息
- 批准号:2185412
- 负责人:
- 金额:$ 11.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-08-01 至 1998-07-31
- 项目状态:已结题
- 来源:
- 关键词:RNA X ray crystallography antibody antibody specificity antiserum autoantibody chemical binding computer simulation conformation human genetic material tag human tissue hybrid antibody immune complex immunoglobulin genes immunoglobulin structure laboratory mouse molecular cloning monoclonal antibody mutant nuclear magnetic resonance spectroscopy nucleic acid sequence physical model polymerase chain reaction protein sequence protein structure function ribonucleoproteins site directed mutagenesis systemic lupus erythematosus
项目摘要
This proposal outlines a research effort to further our understanding of
the structural rules that dictate protein-RNA interaction. The role of
specific amino acids and nucleotides in the formation of an antibody-RNA
complex will be delineated using antibodies that bind to stem-loop II of U1
RNA. The study of RNA-protein interactions in the context of anti-U1 RNA
antibodies will allow for relatively simple assessment of the RNA binding
site due to the small size of antigen binding regions and the known
structures of several antibodies. Experiments in this proposal are
designed to: 1) characterize naturally occurring U1 RNA-stem loop II
antibodies and produce genetically engineered U1 RNA-binding antibody
fragments (Fabs); 2) analyze the RNA binding sites contained in the
naturally occurring and recombinant Fabs by evaluation of amino acid
sequence, antibody specificity and binding characteristics; 3) determine
the role of specific amino acids in binding U1 RNA by the use of molecular
modeling and site-directed mutagenesis; 4) elucidate the ribonucleotides
critical to antibody binding using a rapid selection technique and; 5)
initiate NMR and crystallographic studies with the long-term goal of
elucidating the structure of an RNA antibody and/or antibody-RNA complex.
U1 RNA, as well as many other cellular RNAs, exist in the cell as
ribonucleoproteins functioning in RNA processing and gene regulation.
These ribonucleoproteins are often targeted by the immune system in
patients with autoimmune diseases such as systemic lupus erythematosus
(SLE), Sjogren's syndrome, and rheumatoid arthritis. This research will
improve our understanding of RNA-protein recognition and gene regulation.
A better understanding of these processes will help discern the cellular
disregulation associated with autoimmune disease. In addition, information
gained will impact on our knowledge of the structure of RNA-reactive
antibodies and will have future application in the design of novel
therapeutic antibodies and nucleic acid autoantibody inhibitors.
该提案概述了一项研究工作,以进一步了解
决定蛋白质-RNA相互作用的结构规则。 的作用
抗体-RNA形成中的特定氨基酸和核苷酸
将使用结合U1的茎环II的抗体描绘复合物
核糖核酸 抗U1 RNA背景下RNA-蛋白质相互作用的研究
抗体将允许相对简单地评估RNA结合
由于抗原结合区的小尺寸和已知的
几种抗体的结构。 该提案的实验是
设计用于:1)表征天然存在的U1 RNA-茎环II
抗体并产生基因工程U1 RNA结合抗体
片段(Fab); 2)分析包含在Fab中的RNA结合位点。
天然存在的和重组Fab,通过评估氨基酸
序列、抗体特异性和结合特性; 3)确定
利用分子生物学技术研究了特定氨基酸在结合U1 RNA中的作用。
建模和定点突变; 4)阐明核糖核苷酸
使用快速选择技术对抗体结合至关重要; 5)
启动核磁共振和晶体学研究,长期目标是
阐明RNA抗体和/或抗体-RNA复合物的结构。
U1 RNA和许多其他细胞RNA一样存在于细胞中,
在RNA加工和基因调节中起作用的核糖核蛋白。
这些核糖核蛋白通常被免疫系统靶向,
系统性红斑狼疮等自身免疫性疾病患者
(SLE)干燥综合征和类风湿性关节炎。 这项研究将
提高我们对RNA-蛋白质识别和基因调控的理解。
更好地理解这些过程将有助于辨别细胞
与自身免疫性疾病相关的失调。 此外,信息
这将影响我们对RNA反应性蛋白质结构的认识。
抗体,并将有未来的应用在设计新的
治疗性抗体和核酸自身抗体抑制剂。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The use of Ni-nitrilotriacetic acid agarose for estimation of affinities of hexahistidine-tagged Fab to single-stranded DNA.
使用 Ni-次氮基三乙酸琼脂糖估计六组氨酸标记的 Fab 与单链 DNA 的亲和力。
- DOI:10.1006/abio.1997.2051
- 发表时间:1997
- 期刊:
- 影响因子:2.9
- 作者:Komissarov,AA;Marchbank,MT;Deutscher,SL
- 通讯作者:Deutscher,SL
Isolation and characterization of nucleic acid-binding antibody fragments from autoimmune mice-derived bacteriophage display libraries.
从自身免疫小鼠衍生的噬菌体展示文库中分离和表征核酸结合抗体片段。
- DOI:10.1016/0378-1119(93)90254-z
- 发表时间:1993
- 期刊:
- 影响因子:3.5
- 作者:Calcutt,MJ;Kremer,MT;Giblin,MF;Quinn,TP;Deutscher,SL
- 通讯作者:Deutscher,SL
Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries.
- DOI:10.1006/jmbi.1997.1107
- 发表时间:1997-07
- 期刊:
- 影响因子:5.6
- 作者:E. Peletskaya;V. V. Glinsky-V.;G. Glinsky;S. Deutscher;T. Quinn
- 通讯作者:E. Peletskaya;V. V. Glinsky-V.;G. Glinsky;S. Deutscher;T. Quinn
Site-specific mutagenesis of a recombinant anti-single-stranded DNA Fab. Role of heavy chain complementarity-determining region 3 residues in antigen interaction.
重组抗单链 DNA Fab 的定点诱变。
- DOI:10.1074/jbc.272.43.26864
- 发表时间:1997
- 期刊:
- 影响因子:0
- 作者:Komissarov,AA;Marchbank,MT;Calcutt,MJ;Quinn,TP;Deutscher,SL
- 通讯作者:Deutscher,SL
Thermodynamics of Fab-ssDNA interactions: contribution of heavy chain complementarity determining region 3.
Fab-ssDNA 相互作用的热力学:重链互补决定区 3 的贡献。
- DOI:10.1021/bi991347l
- 发表时间:1999
- 期刊:
- 影响因子:2.9
- 作者:Komissarov,AA;Deutscher,SL
- 通讯作者:Deutscher,SL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN L DEUTSCHER其他文献
SUSAN L DEUTSCHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN L DEUTSCHER', 18)}}的其他基金
Targeting TF/CD44v6 for In Vivo Nano-generated alpha-therapy of Ovarian Cancer
靶向 TF/CD44v6 用于卵巢癌体内纳米α疗法
- 批准号:
8769083 - 财政年份:2014
- 资助金额:
$ 11.03万 - 项目类别:
Targeting TF/CD44v6 for In Vivo Nano-generated alpha-therapy of Ovarian Cancer
靶向 TF/CD44v6 体内纳米α疗法治疗卵巢癌
- 批准号:
8878206 - 财政年份:2014
- 资助金额:
$ 11.03万 - 项目类别:
Multivalent Nanophage Engineered as Dual Receptor Cancer Theranostic Agents.
多价纳米噬菌体被设计为双受体癌症治疗剂。
- 批准号:
8569062 - 财政年份:2013
- 资助金额:
$ 11.03万 - 项目类别:
Phage Display for Improved Peptide-Based Tumor Targeting and Imaging Agents
用于改进基于肽的肿瘤靶向和成像剂的噬菌体展示
- 批准号:
10343781 - 财政年份:2011
- 资助金额:
$ 11.03万 - 项目类别:
Phage Display for Improved Peptide-based Tumor Targeting and Imaging Agents
用于改进基于肽的肿瘤靶向和成像剂的噬菌体展示
- 批准号:
8263685 - 财政年份:2011
- 资助金额:
$ 11.03万 - 项目类别:
Phage Display for Improved Peptide-Based Tumor Targeting and Imaging Agents
用于改进基于肽的肿瘤靶向和成像剂的噬菌体展示
- 批准号:
10554256 - 财政年份:2011
- 资助金额:
$ 11.03万 - 项目类别:
Phage Display for Improved Peptide-Based Tumor Targeting and Imaging Agents
用于改进基于肽的肿瘤靶向和成像剂的噬菌体展示
- 批准号:
10115970 - 财政年份:2011
- 资助金额:
$ 11.03万 - 项目类别:
Phage Display for Improved Peptide-based Tumor Targeting and Imaging Agents
用于改进基于肽的肿瘤靶向和成像剂的噬菌体展示
- 批准号:
8398936 - 财政年份:2011
- 资助金额:
$ 11.03万 - 项目类别:
Phage Display for Improved Peptide-Based Tumor Targeting and Imaging Agents
用于改进基于肽的肿瘤靶向和成像剂的噬菌体展示
- 批准号:
9236073 - 财政年份:2011
- 资助金额:
$ 11.03万 - 项目类别:
Phage Display for Improved Peptide-based Tumor Targeting and Imaging Agents
用于改进基于肽的肿瘤靶向和成像剂的噬菌体展示
- 批准号:
8138754 - 财政年份:2011
- 资助金额:
$ 11.03万 - 项目类别:
相似海外基金
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - PROTEIN EXPRESSION AND/OR X-RAY CRYSTALLOGRAPHY
化学筛选和优化设施 - 蛋白质表达和/或 X 射线晶体学
- 批准号:
10942884 - 财政年份:2023
- 资助金额:
$ 11.03万 - 项目类别:
Taking Snapshots of Enzymatic Reactions Using X-ray Crystallography and Spectroscopy
使用 X 射线晶体学和光谱学拍摄酶反应快照
- 批准号:
10623717 - 财政年份:2023
- 资助金额:
$ 11.03万 - 项目类别:
EAGER: JOINT CRYO NEUTRON/X-RAY CRYSTALLOGRAPHY OF RNA AND RNA-PROTEIN INTERACTIONS
EAGER:RNA 和 RNA-蛋白质相互作用的联合冷冻中子/X 射线晶体学
- 批准号:
2224897 - 财政年份:2022
- 资助金额:
$ 11.03万 - 项目类别:
Standard Grant
Protein structure-based enhancement of enzyme performance for food and bioproduct applications using X-ray crystallography, protein modification and metabolic engineering methods
使用 X 射线晶体学、蛋白质修饰和代谢工程方法,基于蛋白质结构增强食品和生物产品应用中的酶性能
- 批准号:
RGPIN-2016-06209 - 财政年份:2021
- 资助金额:
$ 11.03万 - 项目类别:
Discovery Grants Program - Individual
Time-Resolved X-ray Crystallography of Dynamics in Cysteine-Dependent Enzymes
半胱氨酸依赖性酶动力学的时间分辨 X 射线晶体学
- 批准号:
10684770 - 财政年份:2020
- 资助金额:
$ 11.03万 - 项目类别:
Time-Resolved X-ray Crystallography of Dynamics in Cysteine-Dependent Enzymes
半胱氨酸依赖性酶动力学的时间分辨 X 射线晶体学
- 批准号:
10259757 - 财政年份:2020
- 资助金额:
$ 11.03万 - 项目类别:
Elucidating the Hidden Steps of Replicative DNA Synthesis by Time-Resolved X-ray Crystallography
通过时间分辨 X 射线晶体学阐明复制 DNA 合成的隐藏步骤
- 批准号:
2001434 - 财政年份:2020
- 资助金额:
$ 11.03万 - 项目类别:
Standard Grant
Time-Resolved X-ray Crystallography of Dynamics in Cysteine-Dependent Enzymes
半胱氨酸依赖性酶动力学的时间分辨 X 射线晶体学
- 批准号:
10099548 - 财政年份:2020
- 资助金额:
$ 11.03万 - 项目类别:
Optimizing protein expression for X-ray crystallography studies and medicinal chemistry
优化 X 射线晶体学研究和药物化学的蛋白质表达
- 批准号:
552236-2020 - 财政年份:2020
- 资助金额:
$ 11.03万 - 项目类别:
University Undergraduate Student Research Awards
Protein structure-based enhancement of enzyme performance for food and bioproduct applications using X-ray crystallography, protein modification and metabolic engineering methods
使用 X 射线晶体学、蛋白质修饰和代谢工程方法,基于蛋白质结构增强食品和生物产品应用中的酶性能
- 批准号:
RGPIN-2016-06209 - 财政年份:2020
- 资助金额:
$ 11.03万 - 项目类别:
Discovery Grants Program - Individual